The optimal concentration for over-the-counter products typically ranges from 0.1% to 2% GHK-Cu, with many studies suggesting 0.5% as an effective sweet spot for benefits without adverse reactions
The pivotal SURPASS clinical trial program for type 2 diabetes enrolled over 10,000 participants across multiple international sites, demonstrating tirzepatide's efficacy across a range of baseline characteristics and disease severities
Sample sizes reflected the number of available matched pairs after implementing 1:1 PSM through nearest-neighbor algorithms
Track: Weekly weight (same day, same time, same conditions) Measurements (waist, hips, chestmore reliable than scale alone) Side effects (what you feel, when, how severe) Food intake (even rough estimates help) PeptIQ makes this simplelog doses, track inventory, monitor your response over time
Individual outcomes vary based on adherence to diet, exercise, and metabolic genetics